19 results on '"Barbre, Kira"'
Search Results
2. Influenza and Up-to-Date COVID-19 Vaccination Coverage Among Health Care Personnel--National Healthcare Safety Network, United States, 2022-23 Influenza Season
- Author
-
Bell, Jeneita, Meng, Lu, Barbre, Kira, Haanschoten, Emily, Reses, Hannah E., Soe, Minn, Edwards, Jonathan, Massey, Jason, Reddy, Gnanendra Reddy Tugu Yagama, Woods, Austin, Stuckey, Matthew J., Kuhar, David T., Bolden, Kayla, Dubendris, Heather, Wong, Emily, Rowe, Theresa, Lindley, Megan C., Kalayil, Elizabeth J., and Benin, Andrea
- Subjects
Vaccination ,Hospitals -- West Virginia ,Influenza vaccines ,Influenza ,Evidence-based medicine ,Medical personnel ,Health - Abstract
Introduction Vaccination of health care personnel (HCP) is a critical strategy to minimize transmission of infection in health care settings (1,2). HCP are at high risk for work-related exposure to [...]
- Published
- 2023
3. Declines in Influenza Vaccination Coverage Among Health Care Personnel in Acute Care Hospitals During the COVID-19 Pandemic--United States, 2017-2023
- Author
-
Lymon, Hoody, Meng, Lu, Reses, Hannah E., Barbre, Kira, Dubendris, Heather, Shafi, Shanjeeda, Wiegand, Ryan, Reddy, Gnanendra Reddy Tugu Yagama, Woods, Austin, Kuhar, David T., Stuckey, Matthew J., Lindley, Megan C., Haas, Lori, Qureshi, Iram, Wong, Emily, Benin, Andrea, and Bell, Jeneita M.
- Subjects
Epidemics -- Health aspects ,Vaccination -- Health aspects ,Mortality ,Influenza vaccines -- Health aspects ,Influenza -- Health aspects ,Evidence-based medicine -- Health aspects ,Medical personnel -- Health aspects ,Health - Abstract
Introduction Health care personnel (HCP), including those working in acute care hospitals, are at risk for becoming infected with influenza, missing work due to illness, and transmitting the virus to [...]
- Published
- 2023
4. Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria
- Author
-
Anagbogu, Ifeoma N., Saka, Yisa A., Surakat, Olabanji Ahmed, Okoronkwo, Chukwu, Davies, Emmanuel, Oyale, Philip, Ekpo , Uwem Friday, Amazigo, Uche V., Barbre, Kira, Igbe, Micheal, Nyior, Audrey, Jacob, Solomon M, Gideon Nteun, Uduak, and Abubakar Umar, Zaiyanatu
- Published
- 2022
- Full Text
- View/download PDF
5. Disparities in COVID-19 Vaccination Status Among Long-Term Care Facility Residents--United States, October 31, 2022-May 7, 2023
- Author
-
Haanschoten, Emily, Dubendris, Heather, Reses, Hannah E., Barbre, Kira, Meng, Lu, Benin, Andrea, and Bell, Jeneita M.
- Subjects
United States. Department of Health and Human Services -- Analysis ,Social service -- Analysis -- Health aspects ,Vaccination -- Health aspects -- Analysis ,Infection -- Health aspects -- Analysis ,Long-term care of the sick -- Analysis -- Health aspects ,Long-term care facilities -- Health aspects -- Analysis ,African Americans -- Analysis -- Health aspects ,Health - Abstract
Introduction Long-term care (LTC) facility residents are vulnerable to SARS-CoV-2 infection because of their often-advanced age, medical complexity, and congregate setting (1). Vaccination against COVID-19 effectively reduces severe COVID-19 among [...]
- Published
- 2023
6. Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents--United States, November 20, 2022-January 8, 2023
- Author
-
Wong, Emily, Barbre, Kira, Wiegand, Ryan E., Reses, Hannah E., Dubendris, Heather, Wallace, Megan, Dollard, Philip, Edwards, Jonathan, Soe, Minn, Meng, Lu, Benin, Andrea, and Bell, Jeneita M.
- Subjects
Vaccination -- Health aspects ,Infection -- Health aspects ,RNA -- Health aspects ,Nursing homes -- Health aspects ,Health - Abstract
Nursing home residents have been disproportionately affected by the COVID-19 pandemic; their age, comorbidities, and exposure to a congregate setting has placed them at high risk for both infection and [...]
- Published
- 2023
7. COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19–Associated Hospitalization Among Residents in Nursing Homes — National Healthcare Safety Network, United States, October 2023–February 2024.
- Author
-
Franklin, David, Barbre, Kira, Rowe, Theresa A., Reses, Hannah E., Massey, Jason, Lu Meng, Dollard, Philip, Dubendris, Heather, Stillions, Molly, Robinson, Lindsay, Clerville, Jacques W., Slifka, Kara Jacobs, Benin, Andrea, and Bell, Jeneita M.
- Subjects
- *
NURSING , *SARS-CoV-2 , *HOSPITAL care , *COVID-19 vaccines , *HEALTH outcome assessment - Abstract
Nursing home residents are at increased risk for developing severe COVID-19. Nursing homes report weekly facilitylevel data on SARS-CoV-2 infections, COVID-19–associated hospitalizations, and COVID-19 vaccination coverage among residents to CDC’s National Healthcare Safety Network. This analysis describes rates of incident SARS-CoV-2 infection, rates of incident COVID-19–associated hospitalization, and COVID-19 vaccination coverage during October 16, 2023– February 11, 2024. Weekly rates of SARS-CoV-2 infection ranged from 61.4 to 133.8 per 10,000 nursing home residents. The weekly percentage of facilities reporting one or more incident SARS-CoV-2 infections ranged from 14.9% to 26.1%. Weekly rates of COVID-19–associated hospitalization ranged from 3.8 to 7.1 per 10,000 residents, and the weekly percentage of facilities reporting one or more COVID-19–associated hospitalizations ranged from 2.6% to 4.7%. By February 11, 2024, 40.5% of nursing home residents had received a dose of the updated 2023–2024 COVID-19 vaccine that was first recommended in September 2023. Although the peak rate of SARS-CoV-2 infection among nursing home residents was lower during the 2023–24 respiratory virus season than during the three previous respiratory virus seasons, nursing home residents continued to be disproportionately affected by SARS-CoV-2 infection and related severe outcomes. Vaccination coverage remains suboptimal in this population. Ongoing surveillance for SARS-CoV-2 infections and COVID-19–associated hospitalizations in this population is necessary to develop and evaluate evidence-based interventions for protecting nursing home residents. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves -- United States, June 30, 2021-September 27, 2022.
- Author
-
Navarrete, Jose, Barone, Gregory, Qureshi, Iram, Woods, Austin, Barbre, Kira, Lu Meng, Novosad, Shannon, Qunna Li, Soe, Minn Minn, Edwards, Jonathan, Wong, Emily, Reses, Hannah E., Guthrie, Sydney, Keenan, John, Lamping, Leticia, Park, Meeyoung, Dumbuya, Sorie, Benin, Andrea L., and Bell, Jeneita
- Subjects
CORONAVIRUS diseases ,HEMODIALYSIS ,DISEASE incidence ,VIRAL vaccines ,DISEASE risk factors - Abstract
Persons receiving maintenance dialysis are at increased risk for SARS-CoV-2 infection and its severe outcomes, including death. However, rates of SARS-CoV-2 infection and COVID-19-related deaths in this population are not well described. Since November 2020, CDC's National Healthcare Safety Network (NHSN) has collected weekly data monitoring incidence of SARS-CoV-2 infections (defined as a positive SARS-CoV-2 test result) and COVID-19-related deaths (defined as the death of a patient who had not fully recovered from a SARS-CoV-2 infection) among maintenance dialysis patients. This analysis used NHSN dialysis facility COVID-19 data reported during June 30, 2021-September 27, 2022, to describe rates of SARS-CoV-2 infection and COVID-19-related death among maintenance dialysis patients. The overall infection rate was 30.47 per 10,000 patient-weeks (39.64 among unvaccinated patients and 27.24 among patients who had completed a primary COVID-19 vaccination series). The overall death rate was 1.74 per 10,000 patient-weeks. Implementing recommended infection control measures in dialysis facilities and ensuring patients and staff members are up to date with recommended COVID-19 vaccination is critical to limiting COVID-19-associated morbidity and mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Positive-case follow up for lymphatic filariasis after a transmission assessment survey in Haiti.
- Author
-
Hast, Marisa A., Javel, Alain, Denis, Eurica, Barbre, Kira, Rigodon, Jonas, Robinson, Keri, Brant, Tara A., Wiegand, Ryan, Gass, Katherine, Telfort, Marc Aurèle, and Dubray, Christine
- Subjects
FILARIASIS ,JUDGMENT sampling ,PARASITIC diseases ,STATISTICAL sampling ,CITIES & towns ,INFECTION - Abstract
Background: Lymphatic filariasis (LF) has been targeted for global elimination as a public health problem since 1997. The primary strategy to interrupt transmission is annual mass drug administration (MDA) for ≥5 years. The transmission assessment survey (TAS) was developed as a decision-making tool to measure LF antigenemia in children to determine when MDA in a region can be stopped. The objective of this study was to investigate potential sampling strategies for follow-up of LF-positive children identified in TAS to detect evidence of ongoing transmission. Methodology/Principle findings: Nippes Department in Haiti passed TAS 1 with 2 positive cases and stopped MDA in 2015; however, 8 positive children were found during TAS 2 in 2017, which prompted a more thorough assessment of ongoing transmission. Purposive sampling was used to select the closest 50 households to each index case household, and systematic random sampling was used to select 20 households from each index case census enumeration area. All consenting household members aged ≥2 years were surveyed and tested for circulating filarial antigen (CFA) using the rapid filarial test strip and for Wb123-specific antibodies using the Filaria Detect IgG4 ELISA. Among 1,927 participants, 1.5% were CFA-positive and 4.5% were seropositive. CFA-positive individuals were identified for 6 of 8 index cases. Positivity ranged from 0.4–2.4%, with highest positivity in the urban commune Miragoane. Purposive sampling found the highest number of CFA-positives (17 vs. 9), and random sampling found a higher percent positive (2.4% vs. 1.4%). Conclusions/Significance: Overall, both purposive and random sampling methods were reasonable and achievable methods of TAS follow-up in resource-limited settings. Both methods identified additional CFA-positives in close geographic proximity to LF-positive children found by TAS, and both identified strong signs of ongoing transmission in the large urban commune of Miragoane. These findings will help inform standardized guidelines for post-TAS surveillance. Author summary: Lymphatic filariasis (LF) is a debilitating parasitic disease that has been targeted for global elimination. The transmission assessment survey (TAS) is a tool used to determine if LF transmission has reached low enough levels that prevention activities can be stopped. This study aimed to identify methods to investigate positive LF cases found during TAS. The investigation was conducted in Nippes Department, Haiti, where 8 positive cases were found in TAS in 2017. Participants were recruited through two methods: purposive selection of the closest 50 households to the positive case, and random selection of 20 households in the census enumeration area of the case. Participants completed a survey and were tested for LF antigen, indicative of current infection, and parasite-specific antibody, indicative of current or past infection. A total of 1,927 people participated in the study; 1.5% of these were antigen-positive, and 4.5% were antibody-positive. Purposive sampling found a higher number of antigen-positive individuals, and random sampling found a higher percent positive. Both sampling methods were feasible to use in this setting, and both methods identified signs of ongoing transmission in a large urban area. Additional research is needed to help standardize guidance for post-TAS surveillance to best identify ongoing transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
- Author
-
Cromwell, Elizabeth A., Osborne, Joshua C. P., Unnasch, Thomas R., Basáñez, Maria-Gloria, Gass, Katherine M., Barbre, Kira A., Hill, Elex, Johnson, Kimberly B., Donkers, Katie M., Shirude, Shreya, Schmidt, Chris A., Adekanmbi, Victor, Adetokunboh, Olatunji O., Afarideh, Mohsen, Ahmadpour, Ehsan, Ahmed, Muktar Beshir, Akalu, Temesgen Yihunie, Al-Aly, Ziyad, Alanezi, Fahad Mashhour, and Alanzi, Turki M.
- Subjects
ONCHOCERCIASIS ,RECEIVER operating characteristic curves ,REGRESSION trees ,ENVIRONMENTAL indicators - Abstract
Recent evidence suggests that, in some foci, elimination of onchocerciasis from Africa may be feasible with mass drug administration (MDA) of ivermectin. To achieve continental elimination of transmission, mapping surveys will need to be conducted across all implementation units (IUs) for which endemicity status is currently unknown. Using boosted regression tree models with optimised hyperparameter selection, we estimated environmental suitability for onchocerciasis at the 5 × 5-km resolution across Africa. In order to classify IUs that include locations that are environmentally suitable, we used receiver operating characteristic (ROC) analysis to identify an optimal threshold for suitability concordant with locations where onchocerciasis has been previously detected. This threshold value was then used to classify IUs (more suitable or less suitable) based on the location within the IU with the largest mean prediction. Mean estimates of environmental suitability suggest large areas across West and Central Africa, as well as focal areas of East Africa, are suitable for onchocerciasis transmission, consistent with the presence of current control and elimination of transmission efforts. The ROC analysis identified a mean environmental suitability index of 0·71 as a threshold to classify based on the location with the largest mean prediction within the IU. Of the IUs considered for mapping surveys, 50·2% exceed this threshold for suitability in at least one 5 × 5-km location. The formidable scale of data collection required to map onchocerciasis endemicity across the African continent presents an opportunity to use spatial data to identify areas likely to be suitable for onchocerciasis transmission. National onchocerciasis elimination programmes may wish to consider prioritising these IUs for mapping surveys as human resources, laboratory capacity, and programmatic schedules may constrain survey implementation, and possibly delaying MDA initiation in areas that would ultimately qualify. Author summary: As of 2018, it was unknown if onchocerciasis transmission occurred among approximately 2 400 implementation units (IUs; typically, second administrative-level units, such as districts) considered potentially endemic. These IUs have either never been surveyed for onchocerciasis or historical data are not sufficient to define contemporary endemicity status. Given the large number of IUs for which baseline data collection is likely required to achieve continental elimination, there is a need to prioritise areas for surveys to ensure that those suitable for endemic transmission, and therefore potentially eligible for mass drug administration, are able to initiate interventions as soon as possible. We used boosted regression trees to predict environmental suitability for onchocerciasis, with corresponding measures of uncertainty. We summarized the fine scale spatial predictions at the IU level by using receiver operating characteristic (ROC) curve analysis to identify a threshold that maximized agreement with the occurrence locations to identify IUs that may warrant prioritisation for mapping surveys. This analysis suggests that approximately half of the IUs considered for surveys could be classified as environmentally suitable for onchocerciasis. In order to develop an elimination strategy, many national onchocerciasis elimination programmes (NOEPs) need a mechanism to synthesise historical data to define priority areas for surveys. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Interruption of onchocerciasis transmission in Bioko Island: Accelerating the movement from control to elimination in Equatorial Guinea.
- Author
-
Herrador, Zaida, Garcia, Belén, Ncogo, Policarpo, Perteguer, Maria Jesus, Rubio, Jose Miguel, Rivas, Eva, Cimas, Marta, Ordoñez, Guillermo, de Pablos, Silvia, Hernández-González, Ana, Nguema, Rufino, Moya, Laura, Romay-Barja, María, Garate, Teresa, Barbre, Kira, and Benito, Agustín
- Subjects
ONCHOCERCIASIS ,DRUG administration ,ENZYME-linked immunosorbent assay ,IMMUNOGLOBULIN G ,INFECTIOUS disease transmission - Abstract
Background: Onchocerciasis, also known as river blindness, is a parasitic disease. More than 99 percent of all cases occur in Africa. Bioko Island (Equatorial Guinea) is the only island endemic for onchocerciasis in the world. Since 2005, when vector Simulium yahense was eliminated, there have not been any reported cases of infection. This study aimed to demonstrate that updated WHO criteria for stopping mass drug administration (MDA) have been met. Methodology/Principal findings: A cross-sectional study was conducted from September 2016 to January 2017. Participants were 5- to 9-year-old school children. Onchocerciasis/lymphatic Filariasis (LF, only in endemic districts) rapid diagnostic tests (RDTs) were performed. Blood spots were collected from RDT positive children and 10 percent of the RDT negatives to determine Ov16 and Wb123 IgG4 antibodies through enzyme-linked immunosorbent assay (ELISA). Skin snips were collected from RDT positives. Filarial detection was performed by PCR in positives and indeterminate sera. Black fly collection was carried out in traditional breeding sites. A total of 7,052 children, ranging from 5 to 9 years of age, were included in the study. Four children (0.06%) were Ov16 IgG4 RDT positives, but negative by ELISA Ov16, while 6 RDT negative children tested positive by ELISA. A total of 1,230 children from the Riaba and Baney districts were tested for LF. One child was Wb123 RDT positive (0.08%), but ELISA negative, while 3 RDT negative children were positive by Wb123 ELISA. All positive samples were negative by PCR for onchocerciasis and LF (in blood spot and skin snip). All fly collections and larval prospections in the traditional catching and prospection sites were negative. Conclusions/Significance: WHO criteria have been met, therefore MDA in Bioko Island can be stopped. Three years of post-treatment surveillance should be implemented to identify any new occurrences of exposure or infection. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
12. The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania.
- Author
-
Gass, Katherine M., Sime, Heven, Mwingira, Upendo J., Nshala, Andreas, Chikawe, Maria, Pelletreau, Sonia, Barbre, Kira A., Deming, Michael S., and Rebollo, Maria P.
- Subjects
LYMPHATIC diseases ,FILARIASIS ,DRUG administration - Abstract
Endemicity mapping is required to determining whether a district requires mass drug administration (MDA). Current guidelines for mapping LF require that two sites be selected per district and within each site a convenience sample of 100 adults be tested for antigenemia or microfilaremia. One or more confirmed positive tests in either site is interpreted as an indicator of potential transmission, prompting MDA at the district-level. While this mapping strategy has worked well in high-prevalence settings, imperfect diagnostics and the transmission potential of a single positive adult have raised concerns about the strategy’s use in low-prevalence settings. In response to these limitations, a statistically rigorous confirmatory mapping strategy was designed as a complement to the current strategy when LF endemicity is uncertain. Under the new strategy, schools are selected by either systematic or cluster sampling, depending on population size, and within each selected school, children 9–14 years are sampled systematically. All selected children are tested and the number of positive results is compared against a critical value to determine, with known probabilities of error, whether the average prevalence of LF infection is likely below a threshold of 2%. This confirmatory mapping strategy was applied to 45 districts in Ethiopia and 10 in Tanzania, where initial mapping results were considered uncertain. In 42 Ethiopian districts, and all 10 of the Tanzanian districts, the number of antigenemic children was below the critical cutoff, suggesting that these districts do not require MDA. Only three Ethiopian districts exceeded the critical cutoff of positive results. Whereas the current World Health Organization guidelines would have recommended MDA in all 55 districts, the present results suggest that only three of these districts requires MDA. By avoiding unnecessary MDA in 52 districts, the confirmatory mapping strategy is estimated to have saved a total of $9,293,219. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
13. Seroprevalence of Hepatitis E among Boston Area Travelers, 2009-2010.
- Author
-
Barbre, Kira A., Jentes, Emily S., Drobeniuc, Jan, Kamili, Saleem, Hamer, Davidson H., and Barnett, Elizabeth D.
- Published
- 2017
- Full Text
- View/download PDF
14. Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, December 2023.
- Author
-
Reses HE, Dubendris H, Haas L, Barbre K, Ananth S, Rowe T, Mothershed E, Hall E, Wiegand RE, Lindley MC, Meyer S, Patel SA, Benin A, Kroop S, Srinivasan A, and Bell JM
- Subjects
- Humans, United States epidemiology, Aged, COVID-19 Vaccines, SARS-CoV-2, Nursing Homes, Vaccination, Delivery of Health Care, Influenza, Human epidemiology, Influenza, Human prevention & control, COVID-19 epidemiology, COVID-19 prevention & control, Influenza Vaccines, Respiratory Syncytial Virus, Human
- Abstract
Nursing home residents are at risk for becoming infected with and experiencing severe complications from respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Fall 2023 is the first season during which vaccines are simultaneously available to protect older adults in the United States against all three of these respiratory viruses. Nursing homes are required to report COVID-19 vaccination coverage and can voluntarily report influenza and RSV vaccination coverage among residents to CDC's National Healthcare Safety Network. The purpose of this study was to assess COVID-19, influenza, and RSV vaccination coverage among nursing home residents during the current 2023-24 respiratory virus season. As of December 10, 2023, 33.1% of nursing home residents were up to date with vaccination against COVID-19. Among residents at 20.2% and 19.4% of facilities that elected to report, coverage with influenza and RSV vaccines was 72.0% and 9.8%, respectively. Vaccination varied by U.S. Department of Health and Human Services region, social vulnerability index level, and facility size. There is an urgent need to protect nursing home residents against severe outcomes of respiratory illnesses by continuing efforts to increase vaccination against COVID-19 and influenza and discussing vaccination against RSV with eligible residents during the ongoing 2023-24 respiratory virus season., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- Published
- 2023
- Full Text
- View/download PDF
15. Influenza and Up-to-Date COVID-19 Vaccination Coverage Among Health Care Personnel - National Healthcare Safety Network, United States, 2022-23 Influenza Season.
- Author
-
Bell J, Meng L, Barbre K, Haanschoten E, Reses HE, Soe M, Edwards J, Massey J, Tugu Yagama Reddy GR, Woods A, Stuckey MJ, Kuhar DT, Bolden K, Dubendris H, Wong E, Rowe T, Lindley MC, Kalayil EJ, and Benin A
- Subjects
- Humans, United States epidemiology, COVID-19 Vaccines, Vaccination Coverage, Seasons, Health Personnel, Vaccination, Nursing Homes, Influenza Vaccines, Influenza, Human epidemiology, Influenza, Human prevention & control, COVID-19 epidemiology, COVID-19 prevention & control
- Abstract
The Advisory Committee on Immunization Practices recommends that health care personnel (HCP) receive an annual influenza vaccine and that everyone aged ≥6 months stay up to date with recommended COVID-19 vaccination. Health care facilities report vaccination of HCP against influenza and COVID-19 to CDC's National Healthcare Safety Network (NHSN). During January-June 2023, NHSN defined up-to-date COVID-19 vaccination as receipt of a bivalent COVID-19 mRNA vaccine dose or completion of a primary series within the preceding 2 months. This analysis describes influenza and up-to-date COVID-19 vaccination coverage among HCP working in acute care hospitals and nursing homes during the 2022-23 influenza season (October 1, 2022-March 31, 2023). Influenza vaccination coverage was 81.0% among HCP at acute care hospitals and 47.1% among those working at nursing homes. Up-to-date COVID-19 vaccination coverage was 17.2% among HCP working at acute care hospitals and 22.8% among those working at nursing homes. There is a need to promote evidence-based strategies to improve vaccination coverage among HCP. Tailored strategies might also be useful to reach all HCP with recommended vaccines and protect them and their patients from vaccine-preventable respiratory diseases., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- Published
- 2023
- Full Text
- View/download PDF
16. Declines in Influenza Vaccination Coverage Among Health Care Personnel in Acute Care Hospitals During the COVID-19 Pandemic - United States, 2017-2023.
- Author
-
Lymon H, Meng L, Reses HE, Barbre K, Dubendris H, Shafi S, Wiegand R, Reddy GRTY, Woods A, Kuhar DT, Stuckey MJ, Lindley MC, Haas L, Qureshi I, Wong E, Benin A, and Bell JM
- Subjects
- Humans, United States epidemiology, Vaccination Coverage, Pandemics, Seasons, Health Personnel, Vaccination, Hospitals, Delivery of Health Care, Influenza, Human epidemiology, Influenza, Human prevention & control, COVID-19 epidemiology, COVID-19 prevention & control, Influenza Vaccines
- Abstract
Health care personnel (HCP) are recommended to receive annual vaccination against influenza to reduce influenza-related morbidity and mortality. Every year, acute care hospitals report receipt of influenza vaccination among HCP to CDC's National Healthcare Safety Network (NHSN). This analysis used NHSN data to describe changes in influenza vaccination coverage among HCP in acute care hospitals before and during the COVID-19 pandemic. Influenza vaccination among HCP increased during the prepandemic period from 88.6% during 2017-18 to 90.7% during 2019-20. During the COVID-19 pandemic, the percentage of HCP vaccinated against influenza decreased to 85.9% in 2020-21 and 81.1% in 2022-23. Additional efforts are needed to implement evidence-based strategies to increase vaccination coverage among HCP and to identify factors associated with recent declines in influenza vaccination coverage., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- Published
- 2023
- Full Text
- View/download PDF
17. Disparities in COVID-19 Vaccination Status Among Long-Term Care Facility Residents - United States, October 31, 2022-May 7, 2023.
- Author
-
Haanschoten E, Dubendris H, Reses HE, Barbre K, Meng L, Benin A, and Bell JM
- Subjects
- Humans, United States epidemiology, Long-Term Care, SARS-CoV-2, Nursing Homes, Vaccination, COVID-19 Vaccines, COVID-19 epidemiology, COVID-19 prevention & control
- Abstract
Residents of long-term care (LTC) facilities constitute a population that is vulnerable to SARS-CoV-2 infection; COVID-19 vaccination effectively reduces severe COVID-19 in these settings. To examine demographic differences in primary and up-to-date vaccination status against COVID-19 among LTC facility residents, a descriptive analysis of COVID-19 vaccination data from the National Healthcare Safety Network (NHSN) COVID-19 vaccination data from October 31, 2022, to May 7, 2023, were analyzed. Being up to date was defined as having received a bivalent COVID-19 vaccine dose or having completed a primary vaccination series <2 months earlier. Geographic disparities in vaccination coverage were identified, with substantially lower prevalences of up-to-date status among LTC facility residents in the South (Region 6) (37.7%) and Southeast (Region 4) (36.5%) than among those in the Pacific Northwest (Region 10) (53.3%) and Mountain West (Region 8) (59.6%) U.S. Department of Health and Human Services regions. Up-to-date status was lowest among Black or African American (39.9%) and multiracial (42.2%) LTC facility residents. Strategies to increase up-to-date COVID-19 vaccination among LTC facility residents could include and address these geographic and racial differences., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- Published
- 2023
- Full Text
- View/download PDF
18. Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents - United States, November 20, 2022-January 8, 2023.
- Author
-
Wong E, Barbre K, Wiegand RE, Reses HE, Dubendris H, Wallace M, Dollard P, Edwards J, Soe M, Meng L, Benin A, and Bell JM
- Subjects
- Adult, Humans, Nursing Homes, Pandemics, SARS-CoV-2, United States epidemiology, Vaccination, COVID-19 epidemiology, COVID-19 prevention & control, COVID-19 Vaccines administration & dosage
- Abstract
Nursing home residents have been disproportionately affected by the COVID-19 pandemic; their age, comorbidities, and exposure to a congregate setting has placed them at high risk for both infection and severe COVID-19-associated outcomes, including death (1). Receipt of a primary COVID-19 mRNA vaccination series (2) and monovalent booster doses (3) have been demonstrated to be effective in reducing COVID-19-related morbidity and mortality in this population. Beginning in October 2022, the National Healthcare Safety Network (NHSN) defined up-to-date vaccination as receipt of a bivalent COVID-19 mRNA vaccine dose or completion of a primary series within the preceding 2 months.* The effectiveness of being up to date with COVID-19 vaccination among nursing home residents in preventing SARS-CoV-2 infection is not known. This analysis used NHSN nursing home COVID-19 data reported during November 20, 2022-January 8, 2023, to describe effectiveness of up-to-date vaccination status (versus not being up to date) against laboratory-confirmed SARS-CoV-2 infection among nursing home residents. Adjusting for calendar week, county-level COVID-19 incidence, county-level social vulnerability index (SVI), and facility-level percentage of staff members who were up to date, up-to-date vaccine effectiveness (VE) against infection was 31.2% (95% CI = 29.1%-33.2%). Nursing home residents should stay up to date with recommended age-appropriate COVID-19 vaccination, which now includes an additional bivalent vaccine dose for moderately or severely immunocompromised adults aged ≥65 years to increase protection against SARS-CoV-2 infection., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- Published
- 2023
- Full Text
- View/download PDF
19. Profile of illness in Syrian refugees: A GeoSentinel analysis, 2013 to 2015.
- Author
-
Mockenhaupt FP, Barbre KA, Jensenius M, Larsen CS, Barnett ED, Stauffer W, Rothe C, Asgeirsson H, Hamer DH, Esposito DH, Gautret P, and Schlagenhauf P
- Subjects
- Adolescent, Ambulatory Care Facilities, Berlin epidemiology, Child, Cohort Studies, Communicable Diseases classification, Communicable Diseases epidemiology, Emigrants and Immigrants, Female, Humans, Male, Syria ethnology, Health Status, Mass Screening statistics & numerical data, Refugees statistics & numerical data, Sentinel Surveillance
- Abstract
Screening of 488 Syrian unaccompanied minor refugees (< 18 years-old) in Berlin showed low prevalence of intestinal parasites (Giardia, 7%), positive schistosomiasis serology (1.4%) and absence of hepatitis B. Among 44 ill adult Syrian refugees examined at GeoSentinel clinics worldwide, cutaneous leishmaniasis affected one in three patients; other noteworthy infections were active tuberculosis (11%) and chronic hepatitis B or C (9%). These data can contribute to evidence-based guidelines for infectious disease screening of Syrian refugees.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.